Liu, Dongfang
- Rutgers University · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #23,443
- Rising Star
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$518.3K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#23,443
By linked amount among FY2023 PIs
Earliest Year Loaded
2015
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Liu, Dongfang as a PI. Multi-PI records show the full award amount for context.
- 2R56AI130197-06R56Contact PIThe adaptor protein Crk in immune responsesRutgers University · Pathology (NIH department code)$343Kaward amount
- 7R21CA267368-02R21Contact PICD147-CAR-NK Cells for Hepatocellular Carcinoma TreatmentRutgers University · Pathology (NIH department code)$175.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Liu, Dongfang as a PI.
FY2023 award administered by Rutgers University (NJ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardRutgers University
- 2016$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #7300
- 2018$2M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #1541
- 2020Entered Top 10% NationallyRanked #1541
- 2022$5M Cumulative Funding